# TAD After Chemotherapy in Locally Advanced Breast Cancer

> **NCT05763641** · — · RECRUITING · sponsor: **Hospital Universitari de Bellvitge** · enrollment: 162 (estimated)

## Conditions studied

- Sentinel Lymph Node
- Breast Cancer
- Locally Advanced

## Interventions

- **PROCEDURE:** Target Axillary Dissection

## Key facts

- **NCT ID:** NCT05763641
- **Lead sponsor:** Hospital Universitari de Bellvitge
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-02-01
- **Primary completion:** 2026-06-01
- **Final completion:** 2026-06-01
- **Target enrollment:** 162 (ESTIMATED)
- **Last updated:** 2025-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05763641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05763641, "TAD After Chemotherapy in Locally Advanced Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05763641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*